🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/01/2020 | 91,27 | 93,50 | 91,27 | 92,44 | +0,71% | 2,44% | 684.900 |
| 14/01/2020 | 86,51 | 92,00 | 86,46 | 91,79 | +6,48% | 6,40% | 726.100 |
| 13/01/2020 | 85,82 | 86,46 | 83,76 | 86,20 | +0,62% | 3,15% | 393.800 |
| 10/01/2020 | 87,45 | 87,90 | 85,40 | 85,67 | -2,17% | 2,86% | 432.500 |
| 09/01/2020 | 87,75 | 87,96 | 86,40 | 87,57 | +0,47% | 1,78% | 317.100 |
| 08/01/2020 | 86,95 | 88,00 | 86,39 | 87,16 | +0,29% | 1,85% | 333.000 |
| 07/01/2020 | 86,12 | 87,26 | 85,54 | 86,91 | +0,39% | 2,00% | 291.800 |
| 06/01/2020 | 86,09 | 86,84 | 85,02 | 86,57 | +0,13% | 2,11% | 365.300 |
| 03/01/2020 | 86,64 | 87,64 | 86,20 | 86,46 | -1,37% | 1,66% | 323.400 |
| 02/01/2020 | 88,35 | 88,35 | 87,00 | 87,66 | -0,48% | 1,53% | 356.600 |
| 31/12/2019 | 86,91 | 88,42 | 86,86 | 88,08 | +1,35% | 1,79% | 378.800 |
| 30/12/2019 | 88,65 | 89,26 | 86,77 | 86,91 | -2,16% | 2,81% | 399.600 |
| 27/12/2019 | 89,64 | 89,84 | 88,02 | 88,83 | -0,70% | 2,03% | 276.400 |
| 26/12/2019 | 91,27 | 91,29 | 89,23 | 89,46 | -2,12% | 2,26% | 247.300 |
| 24/12/2019 | 90,89 | 91,42 | 90,27 | 91,40 | +0,55% | 1,27% | 163.900 |
| 23/12/2019 | 90,76 | 91,11 | 89,56 | 90,90 | +0,56% | 1,71% | 279.700 |
| 20/12/2019 | 89,49 | 90,64 | 88,43 | 90,39 | +1,04% | 2,47% | 724.500 |
| 19/12/2019 | 89,82 | 90,41 | 89,26 | 89,46 | -0,28% | 1,28% | 281.300 |
| 18/12/2019 | 89,58 | 89,84 | 88,02 | 89,71 | +0,31% | 2,03% | 434.200 |
| 17/12/2019 | 91,26 | 91,26 | 88,28 | 89,43 | -1,67% | 3,27% | 527.800 |
| 16/12/2019 | 89,35 | 91,51 | 88,42 | 90,95 | +1,47% | 3,46% | 403.300 |
| 13/12/2019 | 92,51 | 93,33 | 88,76 | 89,63 | -4,40% | 4,94% | 545.200 |
| 12/12/2019 | 92,75 | 93,84 | 92,32 | 93,76 | +1,37% | 1,64% | 253.600 |
| 11/12/2019 | 92,89 | 94,58 | 92,26 | 92,49 | -0,58% | 2,50% | 443.200 |
| 10/12/2019 | 91,08 | 93,10 | 91,08 | 93,03 | +2,17% | 2,22% | 503.300 |
| 09/12/2019 | 91,78 | 92,62 | 91,03 | 91,05 | -0,61% | 1,73% | 334.700 |
| 06/12/2019 | 91,00 | 91,91 | 90,98 | 91,61 | +1,53% | 1,02% | 272.700 |
| 05/12/2019 | 91,59 | 91,79 | 89,93 | 90,23 | -1,22% | 2,03% | 362.900 |
| 04/12/2019 | 89,03 | 91,39 | 88,83 | 91,34 | +2,38% | 2,88% | 479.000 |
| 03/12/2019 | 88,67 | 89,92 | 87,55 | 89,22 | -2,83% | 2,67% | 691.200 |